Page 85 - MemoriaBBN-Eng

www.ciber-bbn.es

• Functional optimization and improvement of biocompatibility of long term neural
interfaces.

• Study of cortical reorganization and associated changes to neural plasticity in

the blind.

• P G, z J, d-t A, A-t m, F e, P Jl. Oligo-
Most relevant urAsArAteíAzAhoCesvilésriGuerosernándezedrAz
chitosan polyplexes as carriers for retinal gene delivery.Eur J Pharm Sci. 2013 Jan
scientific
23;48(1-2):323-31.
articles
• llinAres A, BAdesA FJ, morAles r, GArCíA-ArACil n, sABAter Jm, Fernández e. Robotic as-
sessment of the influence of age on upper-limb sensorimotor function.Clin Interv

Aging. 2013;8:879-88.

• WArK hA, shArmA r, mAtheWs Ks, Fernández e, yoo J, Christensen B et Al.. A new
high-density (25 electrodes/mm2) penetrating microelectrode array for recording

and stimulating sub-millimeter neuroanatomical structures.J Neural Eng. 2013
Aug;10(4):045003.

• s d, r n, s G, d v u, t Ad, F e .. Wnt/β-catenin
AnGesomoimonteiiCinoAhoCesernándezet Al
signaling triggers neuron reprogramming and regeneration in the mouse retina.Cell

Rep. 2013;4(2):271-86.

• mArKus BonGArd, dAniel miCol, And eduArdo Fernández. NEV2lkit: A NEW OPEN SOU-
RCE TOOL FOR HANDLING NEURONAL EVENT FILES FROM MULTI-ELECTRODE

RECORDINGS International Journal of Neural Systems. 2013;Vol. 24:1450009
(10 pages).

In the year 2013, the scientific activity of the group has led to the publication of 34
Highlights
articles in national and international journals, 22 of which are indexed in the JCR
and SJR. Also, the members of the group have participated actively in numerous

national and international recognized prestigious conferences, with the highlight

of receiving a prize in 2013 at the IEEE international Systems Conference.

Notably the group has acquired new funding and collaborations in transfer pro-
jects with private companies of important relevance such as the pharmaceuti-

cal group Ferrer International S.L. for the project “Toxicity and safety of a new
therapy with adult stem cells designed to regenerate retinal neural cells, and

in the continuation of the project “ Development of a new generation of multi-

functional intraocular lenses (HORUS)” co-financed with European funding carried
out in collaboration with a consortium of companies oriented at applied R&D.

Currently, public funding has been secured for 5 projects with a total budget of

1.113.9828€, for the continuation of projects launched in previous years.

During this year, the group has been involved in the participation of clinical trials 13
in the field of epilepsy.
20
T
Equally noteworthy, was the interest shown in the group’s active participation in OR
P
the dissemination of scientific activities which is reflected by the numerous appea- RE
rances in the national and international media.
L
A
NU
N
A
N /
B
-B
R
BE
CI

85